Assessment of liquid captopril formulations used in children.
Mulla
H
H
Department of Pharmacy, University Hospitals of Leicester, Leicester, UK. hussain.mulla@uhl-tr.nhs.uk
Hussain
N
N
Tanna
S
S
Lawson
G
G
Manktelow
B N
BN
Tuleu
C
C
Samani
N J
NJ
Pandya
H C
HC
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000097:blood / Q000737:chemistry*; D002216:Captopril / Q000097:blood / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D056687:Off-Label Use; D012996:Solutions; D013607:Tablets; D013810:Therapeutic Equivalency; D055815:Young Adult
D000806:Angiotensin-Converting Enzyme Inhibitors; D012996:Solutions; D013607:Tablets; D002216:Captopril